AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimecheck MV 1mg/500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Prevego Healthcare & Research Private Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Glimecheck MV 1mg/500mg/0.3mg Tablet

Diabetic patients often use Glimepiride/Metformin/Voglibose 1mg/500mg/0.3mg tablets, a triple-combination antidiabetic medication. This formulation manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them with readily available glucose (e.g., sugary foods or juice). Alcohol consumption increases this risk and should be minimized. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Inform your physician about any history of heart disease before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are essential.

Primary Ingredients of Glimecheck MV 1mg/500mg/0.3mg Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Glimecheck MV 1mg/500mg/0.3mg Tablet

Managing type 2 diabetes

Major Benefits of Glimecheck MV 1mg/500mg/0.3mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume the Glimecheck MV 1mg/500mg/0.3mg tablet on an empty stomach.

Common Side effects of Glimecheck MV 1mg/500mg/0.3mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimecheck MV 1mg/500mg/0.3mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Glimecheck MV 1mg/500mg/0.3mg tablets should be taken on an empty stomach.

How Glimecheck MV 1mg/500mg/0.3mg Tablet works:

One tablet of Glimecheck MV contains 1mg, 500mg, and 0.3mg of three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimecheck MV 1mg/500mg/0.3mg tablets with alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimecheck MV 1mg/500mg/0.3mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glimecheck MV 1mg/500mg/0.3mg tablets while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Employing Glimecheck MV 1mg/500mg/0.3mg tablets in individuals with kidney disease carries a high likelihood of adverse effects and is best avoided. Medical advice is essential. Furthermore, this medication is unsuitable for patients experiencing severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Glimecheck MV 1mg/500mg/0.3mg tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. In individuals with mild to moderate liver disease, initiation should involve a low dose; however, it's contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimecheck MV 1mg/500mg/0.3mg Tablet :

Should you forget to take a Glimecheck MV 1mg/500mg/0.3mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Glimecheck MV 1mg/500mg/0.3mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimecheck MV 1mg/500mg/0.3mg Tablet

Glimecheck MV 1mg/500mg/0.3mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 DM.
Glimecheck MV 1mg/500mg/0.3mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, abdominal pain, headache, rash, and respiratory infection.
Glimecheck MV 1mg/500mg/0.3mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. Their use is also contraindicated in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Glimecheck MV 1mg/500mg/0.3mg tablets with alcohol is unsafe. This combination may worsen low blood sugar and raise the risk of lactic acidosis.
Glimecheck MV 1mg/500mg/0.3mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimecheck MV 1mg/500mg/0...
99
MRP 121
18% off